A Pilot Study Investigating Faecal Microbiota After Two Dietary Interventions in Children with Juvenile Idiopathic Arthritis.


Journal

Current microbiology
ISSN: 1432-0991
Titre abrégé: Curr Microbiol
Pays: United States
ID NLM: 7808448

Informations de publication

Date de publication:
07 Jun 2022
Historique:
received: 10 11 2021
accepted: 09 05 2022
entrez: 7 6 2022
pubmed: 8 6 2022
medline: 10 6 2022
Statut: epublish

Résumé

There is evidence for an impact of the gut microbiota on the immune system, which has consequences for inflammatory diseases. Exclusive enteral nutrition (EEN) and the specific carbohydrate diet (SCD) have been demonstrated as effective anti-inflammatory treatments for children with Crohn's disease. We have previously shown an anti-inflammatory effect from these nutritional treatments in children with juvenile idiopathic arthritis (JIA). The aim of this study was to investigate if improved clinical symptoms after EEN or SCD treatment in children with JIA could be linked to changes in faecal microbiota. We included sixteen patients with JIA (age 7-17 years), six for treatment with EEN and ten with SCD. EEN was given for 3-5 weeks and SCD for 4-5 weeks, with clinical and laboratory status assessed before and after treatment. Faecal samples were analysed for microbiota diversity and composition using 16S rRNA gene sequencing. Analyses of the faecal microbiota showed an effect on the overall composition with both interventions; the most striking result was a decreased relative abundance of the genus Faecalibacterium from EEN and of Bifidobacterium from SCD. The α-diversity decreased significantly from SCD (P = 0.04), but not from EEN (P = 0.22). Despite the study cohorts being small, both EEN and SCD were shown to impact the faecal microbiota. Future larger studies with a focus on metagenomics or metabolomics could possibly reveal a link and clarify the clinical effects of those nutritional regimens.

Identifiants

pubmed: 35672613
doi: 10.1007/s00284-022-02899-1
pii: 10.1007/s00284-022-02899-1
pmc: PMC9174309
doi:

Substances chimiques

RNA, Ribosomal, 16S 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

215

Subventions

Organisme : Reumatikerförbundet
ID : R-657931
Organisme : Reumatikerförbundet
ID : R-744331
Organisme : Reumatikerförbundet
ID : R-848441

Informations de copyright

© 2022. The Author(s).

Références

J Rheumatol. 2021 Oct;48(10):1589-1595
pubmed: 33262301
J Med Food. 2019 Nov;22(11):1092-1099
pubmed: 31329006
Proc Natl Acad Sci U S A. 2008 Oct 28;105(43):16731-6
pubmed: 18936492
J Crohns Colitis. 2018 Feb 28;12(3):337-346
pubmed: 29194468
Am J Clin Nutr. 2020 Apr 1;111(4):864-876
pubmed: 32097450
Nucleic Acids Res. 2013 Jan;41(Database issue):D590-6
pubmed: 23193283
Nutrients. 2017 May 28;9(6):
pubmed: 28555037
Front Microbiol. 2018 Mar 06;9:346
pubmed: 29559959
Front Microbiol. 2020 Sep 10;11:580931
pubmed: 33072051
ISME J. 2013 Feb;7(2):269-80
pubmed: 23038174
Front Microbiol. 2016 Jun 15;7:925
pubmed: 27379055
Arthritis Res Ther. 2018 Jan 30;20(1):14
pubmed: 29382366
J Rheumatol. 2004 Feb;31(2):390-2
pubmed: 14760812
Pediatr Rheumatol Online J. 2017 May 26;15(1):46
pubmed: 28549465
FEMS Microbiol Lett. 2010 Sep 1;310(2):138-44
pubmed: 20695899
Clin Exp Rheumatol. 2016 Sep-Oct;34(5):941-945
pubmed: 27383427
Curr Opin Microbiol. 2013 Jun;16(3):255-61
pubmed: 23831042
Aliment Pharmacol Ther. 2017 Oct;46(7):645-656
pubmed: 28815649
Pediatr Rheumatol Online J. 2021 Jun 10;19(1):88
pubmed: 34112181
Nat Methods. 2016 Jul;13(7):581-3
pubmed: 27214047
Pediatr Rheumatol Online J. 2021 Apr 26;19(1):55
pubmed: 33902613
J Rheumatol. 2015 Mar;42(3):521-6
pubmed: 25320218
World J Gastroenterol. 2016 Feb 14;22(6):2111-7
pubmed: 26877615
Pediatr Rheumatol Online J. 2016 Apr 18;14(1):23
pubmed: 27089922
Am J Gastroenterol. 2015 Dec;110(12):1718-29; quiz 1730
pubmed: 26526081
Arthritis Res Ther. 2014 Nov 30;16(6):486
pubmed: 25434931
J Pediatr Gastroenterol Nutr. 2017 Sep;65(3):289-292
pubmed: 28825776
Front Microbiol. 2016 Oct 26;7:1703
pubmed: 27833598
J Allergy Clin Immunol. 2016 Feb;137(2):587-90
pubmed: 26371844
Microorganisms. 2020 Apr 15;8(4):
pubmed: 32326636
Immunol Rev. 2020 Mar;294(1):9-26
pubmed: 31833578
Inflamm Bowel Dis. 2014 May;20(5):861-71
pubmed: 24651582
J Clin Gastroenterol. 2018 Feb;52(2):155-163
pubmed: 28030510
Nutrients. 2017 Aug 04;9(8):
pubmed: 28777338
Eur J Clin Microbiol Infect Dis. 2016 Mar;35(3):363-70
pubmed: 26718942
Nature. 2015 Mar 5;519(7541):92-6
pubmed: 25731162
Arthritis Rheumatol. 2019 Jun;71(6):1000-1010
pubmed: 30592383
Cell Host Microbe. 2014 Mar 12;15(3):382-392
pubmed: 24629344
Scand J Gastroenterol. 2012 Dec;47(12):1454-9
pubmed: 23016828
Microbiome. 2018 Dec 13;6(1):221
pubmed: 30545401
Sci Rep. 2020 Mar 6;10(1):4247
pubmed: 32144387

Auteurs

Lillemor Berntson (L)

Department of Women's and Children's Health, Uppsala University, 75309, Uppsala, Sweden. Lillemor.berntson@kbh.uu.se.

Anders Öman (A)

Department of Women's and Children's Health, Uppsala University, 75309, Uppsala, Sweden.

Lars Engstrand (L)

Centre for Translational Microbiome Research, (CTMR), Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 17177, Stockholm, Sweden.

Johan Dicksved (J)

Department of Animal Nutrition and Management, Swedish University of Agricultural Sciences, Almas Allé 8, 75007, Uppsala, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH